Macular degeneration treatment

Macular degeneration treatment

C026/6361 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.3MB

Downloadable file size: 15.6MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Caption: MODEL RELEASED. Macular degeneration treatment. Close-up of the eyes of 75-year-old female patient receiving an intra-ocular bevacizumab (Avastin) injection to treat macular degeneration and retinal vein thrombosis. Bevacizumab is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. It is usually used in chemotherapy to treat a number of cancers but here is being used to treat age-related eye conditions. Macular degeneration caused damage to the macula, the central area of the retina in the eye, which leads to a loss of vision in the central field of vision. Retinal vein thrombosis, or central retinal vein occlusion, is a blockage of the central retinal vein. As one of only two sources of blood supply to the eye, occlusion of the central retinal vein can lead to blindness.

Release details: Model release available. Property release not required.

Keywords: 75, 75-year-old, 75-years-old, abnormal, adult, age-related, angiogenesis inhibitor, avastin, bevacizumab, blockage, blocked, caucasian, central retinal vein occlusion, close-up, condition, detail, disease, diseased, disorder, drug, drugs, elderly, eye, eyeball, eyes, face, female, healthcare, hospital, human, injection, intra-ocular, intraocular, macula, macular degeneration, medical, medicine, occluded, ocular, old, older, one person, ophthalmic, ophthalmological, ophthalmology, patient, people, retina, retinal, retinal vein thrombosis, seventies, sight, treating, treatment, unhealthy, vision, white, woman

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.